Market Cap
US$58.8b
Last Updated
2020/08/06 23:47 UTC
Data Sources
Company Financials +
Executive Summary
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
Snowflake Analysis
Flawless balance sheet with solid track record.
Similar Companies
Share Price & News
How has CME Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CME has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
0.5%
CME
1.5%
US Capital Markets
3.0%
US Market
1 Year Return
-22.3%
CME
5.5%
US Capital Markets
15.8%
US Market
Return vs Industry: CME underperformed the US Capital Markets industry which returned 6.3% over the past year.
Return vs Market: CME underperformed the US Market which returned 15.4% over the past year.
Shareholder returns
| CME | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.5% | 1.5% | 3.0% |
| 30 Day | -1.0% | 1.0% | 6.0% |
| 90 Day | -9.7% | 11.2% | 16.4% |
| 1 Year | -20.1%-22.3% | 7.7%5.5% | 18.4%15.8% |
| 3 Year | 45.1%32.0% | 24.7%17.2% | 44.8%35.4% |
| 5 Year | 104.5%67.8% | 56.2%41.1% | 75.7%56.7% |
Price Volatility Vs. Market
How volatile is CME Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
What Can We Learn About CME Group's (NASDAQ:CME) CEO Compensation?1 month ago | Simply Wall St
Has CME Group Inc. (NASDAQ:CME) Improved Earnings Growth In Recent Times?5 months ago | Simply Wall St
Be Sure To Check Out CME Group Inc. (NASDAQ:CME) Before It Goes Ex-DividendValuation
Is CME Group undervalued compared to its fair value and its price relative to the market?
24.68x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CME ($163.97) is trading above our estimate of fair value ($112.59)
Significantly Below Fair Value: CME is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CME is good value based on its PE Ratio (24.7x) compared to the US Capital Markets industry average (28.2x).
PE vs Market: CME is poor value based on its PE Ratio (24.7x) compared to the US market (18.5x).
Price to Earnings Growth Ratio
PEG Ratio: CME is poor value based on its PEG Ratio (3.3x)
Price to Book Ratio
PB vs Industry: CME is good value based on its PB Ratio (2.2x) compared to the US Capital Markets industry average (8.7x).
Next Steps
Future Growth
How is CME Group forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
7.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CME's forecast earnings growth (7.5% per year) is above the savings rate (2.2%).
Earnings vs Market: CME's earnings (7.5% per year) are forecast to grow slower than the US market (22.6% per year).
High Growth Earnings: CME's earnings are forecast to grow, but not significantly.
Revenue vs Market: CME's revenue (3.1% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: CME's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CME's Return on Equity is forecast to be low in 3 years time (9.7%).
Next Steps
Past Performance
How has CME Group performed over the past 5 years?
13.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CME has high quality earnings.
Growing Profit Margin: CME's current net profit margins (46.5%) are higher than last year (39.4%).
Past Earnings Growth Analysis
Earnings Trend: CME's earnings have grown by 13.8% per year over the past 5 years.
Accelerating Growth: CME's earnings growth over the past year (31.2%) exceeds its 5-year average (13.8% per year).
Earnings vs Industry: CME earnings growth over the past year (31.2%) exceeded the Capital Markets industry 16.6%.
Return on Equity
High ROE: CME's Return on Equity (8.9%) is considered low.
Next Steps
Financial Health
How is CME Group's financial position?
Financial Position Analysis
Short Term Liabilities: CME's short term assets ($81.8B) exceed its short term liabilities ($80.2B).
Long Term Liabilities: CME's short term assets ($81.8B) exceed its long term liabilities ($10.2B).
Debt to Equity History and Analysis
Debt Level: CME's debt to equity ratio (10.5%) is considered satisfactory.
Reducing Debt: CME's debt to equity ratio has reduced from 10.5% to 10.5% over the past 5 years.
Debt Coverage: CME's debt is well covered by operating cash flow (98.4%).
Interest Coverage: CME earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is CME Group current dividend yield, its reliability and sustainability?
3.60%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CME's dividend (3.6%) is higher than the bottom 25% of dividend payers in the US market (1.65%).
High Dividend: CME's dividend (3.6%) is low compared to the top 25% of dividend payers in the US market (4.45%).
Stability and Growth of Payments
Stable Dividend: CME's dividend payments have been volatile in the past 10 years.
Growing Dividend: CME's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (48.2%), CME's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CME's dividends in 3 years are not forecast to be well covered by earnings (99.5% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
9.5yrs
Average management tenure
CEO
Terry Duffy (62 yo)
3.75yrs
Tenure
US$11,867,214
Compensation
Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group Inc since November 15, 2016. Mr. Duffy is the Chief Executive Officer at New York Mercantile Exchange, ...
CEO Compensation Analysis
Compensation vs Market: Terry's total compensation ($USD11.87M) is about average for companies of similar size in the US market ($USD11.29M).
Compensation vs Earnings: Terry's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 3.75yrs | US$11.87m | 0.019% $ 11.2m | |
| Chief Financial Officer | 5.67yrs | US$3.30m | 0.011% $ 6.5m | |
| Senior MD & COO | 5.92yrs | US$3.00m | 0.011% $ 6.2m | |
| Senior MD & Chief Information Officer | 12.08yrs | US$2.82m | 0.021% $ 12.3m | |
| MD & Chief Accounting Officer | 5.5yrs | no data | 0.0050% $ 2.9m | |
| Managing Director of Investor Relations | no data | no data | no data | |
| Senior MD | 17.75yrs | no data | 0.013% $ 7.8m | |
| Senior Managing Director of Corporate Marketing & Communications | 13.5yrs | no data | no data | |
| Senior MD & Chief Human Resources Officer | 13yrs | no data | 0.011% $ 6.6m | |
| Managing Director of Organizational Development | 17.75yrs | no data | no data | |
| Managing Director of Data Centers & Critical Infrastructure | 9.5yrs | no data | no data | |
| Senior Managing Director of International & Optimization Services | 0.58yr | no data | 0.0033% $ 1.9m |
9.5yrs
Average Tenure
55yo
Average Age
Experienced Management: CME's management team is seasoned and experienced (9.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 3.75yrs | US$11.87m | 0.019% $ 11.2m | |
| Independent Lead Director | 3yrs | US$273.68k | 0.010% $ 5.9m | |
| Independent Director | 16.33yrs | US$258.43k | 0.0044% $ 2.6m | |
| Independent Director | 17.33yrs | US$227.18k | 0.0050% $ 2.9m | |
| Independent Director | 19yrs | US$279.18k | 0.0049% $ 2.9m | |
| Independent Director | 12yrs | US$285.35k | 0.0015% $ 911.5k | |
| Independent Director | 26.58yrs | US$239.68k | 0.0099% $ 5.8m | |
| Independent Director | 23.58yrs | US$233.18k | 0.056% $ 32.6m | |
| Independent Director | 20.58yrs | US$246.68k | 0.023% $ 13.4m | |
| Director | 0.25yr | US$5.70m | 0.023% $ 13.5m | |
| Independent Director | 13.08yrs | US$226.68k | 0.0010% $ 611.6k | |
| Independent Director | 12.25yrs | US$253.18k | 0.0028% $ 1.7m |
16.8yrs
Average Tenure
69yo
Average Age
Experienced Board: CME's board of directors are seasoned and experienced ( 16.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CME insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
CME Group Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: CME Group Inc.
- Ticker: CME
- Exchange: NasdaqGS
- Founded: 1898
- Industry: Financial Exchanges and Data
- Sector: Diversified Financials
- Market Cap: US$58.804b
- Shares outstanding: 358.63m
- Website: https://www.cmegroup.com
Number of Employees
Location
- CME Group Inc.
- 20 South Wacker Drive
- Chicago
- Illinois
- 60606
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MX4A | DB (Deutsche Boerse AG) | Yes | Class A Common Stock | DE | EUR | Dec 2002 |
| CME | NasdaqGS (Nasdaq Global Select) | Yes | Class A Common Stock | US | USD | Dec 2002 |
| 0HR2 | LSE (London Stock Exchange) | Yes | Class A Common Stock | GB | USD | Dec 2002 |
| CMEG | WBAG (Wiener Boerse AG) | Yes | Class A Common Stock | AT | EUR | Dec 2002 |
| CME * | BMV (Bolsa Mexicana de Valores) | Yes | Class A Common Stock | MX | MXN | Dec 2002 |
| CHME34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 4 REP 1 COM USD0.01 CLASS A | BR | BRL | May 2019 |
Biography
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, eq ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/08/06 23:47 |
| End of Day Share Price | 2020/08/06 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.